Literature DB >> 16108849

Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes.

E Black1, C Holst, A Astrup, S Toubro, S Echwald, O Pedersen, T I A Sørensen.   

Abstract

AIM: To investigate if weight gain during adulthood has effects on the risk of developing impaired glucose tolerance (IGT) or Type 2 diabetes beyond effect of attained weight. RESEARCH DESIGN AND METHODS: Data were obtained from a longitudinal study of two cohorts: one of juvenile-onset obese (n = 248) and one of randomly selected control (n = 320) men, weighed at average ages of 20, 33, 44 and 51 years, respectively.
RESULTS: For any given BMI, the risk of IGT was higher the greater the weight gain since age 20 (odds ratio of 1.10 per unit kg/m2 of BMI gain, confidence interval 1.03-1.17, P = 0.004), and weight gain during both the early and later ages contributed to the increased risk. Obese men, maintaining weight since age 20, had lower risk of IGT than non-obese men who became similarly obese by age 51. The risk of Type 2 diabetes increased by weight gain in early adult life, but not by more recent weight gain in the later periods, probably because of the development of Type 2 diabetes leading to weight loss.
CONCLUSIONS: Independent of attained level of body weight in middle-aged men, weight gain is associated with increased risk of IGT, and is greater in those not overweight in childhood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108849     DOI: 10.1111/j.1464-5491.2005.01615.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  23 in total

1.  Differences in weight gain in hypertensive and diabetic elderly patients primary care study.

Authors:  Z Jancso; E Halmy; I Rurik
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

2.  Chronic family stress moderates the association between a TOMM40 variant and triglyceride levels in two independent Caucasian samples.

Authors:  Rong Jiang; Beverly H Brummett; Elizabeth R Hauser; Michael A Babyak; Ilene C Siegler; Abanish Singh; Arne Astrup; Oluf Pedersen; Torben Hansen; Claus Holst; Thorkild I A Sørensen; Redford B Williams
Journal:  Biol Psychol       Date:  2013-02-19       Impact factor: 3.251

3.  Trajectories of total and central adiposity throughout adolescence and cardiometabolic factors in early adulthood.

Authors:  J Araújo; H Barros; E Ramos; L Li
Journal:  Int J Obes (Lond)       Date:  2016-09-28       Impact factor: 5.095

4.  Metabolic syndrome and weight gain in adulthood.

Authors:  Dawn E Alley; Virginia W Chang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-11-11       Impact factor: 6.053

5.  Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial.

Authors:  Dario Tuccinardi; Olivia M Farr; Jagriti Upadhyay; Sabrina M Oussaada; Hannah Mathew; Stavroula A Paschou; Nikolaos Perakakis; Anastasia Koniaris; Theodoros Kelesidis; Christos S Mantzoros
Journal:  Diabetes Obes Metab       Date:  2019-03-18       Impact factor: 6.577

6.  Smoking cessation increases short-term risk of type 2 diabetes irrespective of weight gain: the Japan Public Health Center-Based Prospective Study.

Authors:  Shino Oba; Mitsuhiko Noda; Kayo Waki; Akiko Nanri; Masayuki Kato; Yoshihiko Takahashi; Kalpana Poudel-Tandukar; Yumi Matsushita; Manami Inoue; Tetsuya Mizoue; Shoichiro Tsugane
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

7.  Associations between APOE variants and metabolic traits and the impact of psychological stress.

Authors:  Sofia I Iqbal Kring; John Barefoot; Beverly H Brummett; Stephen H Boyle; Ilene C Siegler; Søren Toubro; Torben Hansen; Arne Astrup; Oluf Pedersen; Redford B Williams; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

8.  Influences of the common FTO rs9939609 variant on inflammatory markers throughout a broad range of body mass index.

Authors:  Esther Zimmermann; Kristin Skogstrand; David M Hougaard; Arne Astrup; Torben Hansen; Oluf Pedersen; Thorkild I A Sørensen; Tine Jess
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

9.  Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.

Authors:  Rachel M Freathy; Gbenga R Kazeem; Richard W Morris; Paul C D Johnson; Lavinia Paternoster; Shah Ebrahim; Andrew T Hattersley; Anita Hill; Aroon D Hingorani; Claus Holst; Barbara J Jefferis; Sofia I I Kring; Vincent Mooser; Sandosh Padmanabhan; Martin Preisig; Susan M Ring; Naveed Sattar; Mark N Upton; Peter Vollenweider; Gerard Waeber; Thorkild I A Sørensen; Timothy M Frayling; Graham Watt; Debbie A Lawlor; Peter H Whincup; Federica Tozzi; George Davey Smith; Marcus Munafò
Journal:  Int J Epidemiol       Date:  2011-05-18       Impact factor: 7.196

10.  Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes.

Authors:  Sofia I I Kring; Thomas Werge; Claus Holst; Søren Toubro; Arne Astrup; Torben Hansen; Oluf Pedersen; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.